Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Banner Life Sciences (25 products)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Portfolio of generic drug products. The portfolio consists of 25 products of Banner Life Sciences and is a mix of high-potency steroidal, antiviral, neurology, over-the-counter pain management and anti-allergy medicines.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Buildings and Property
Other Industries
Other Healthcare
Acquirer
Primary Office
  • Durham, NC
  • United States

Banner Life Sciences (25 products) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Banner Life Sciences (25 products)‘s full profile, request access.

Request full access to PitchBook

Banner Life Sciences (25 products) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Banner Life Sciences (25 products)‘s full profile, request access.

Request full access to PitchBook